Conformis recently launched a patient education and awareness campaign in selected U.S. markets to strengthen the importance of patient choice by highlighting the differences between traditional "off-the-shelf" products and truly personalized knee systems that offer clinically proven benefits to patients. The campaign is currently airing in the Boston, MA and Minneapolis-St. Paul, MN metro areas in an effort to educate future patients about their options when it comes to total knee replacement surgery. Independent surveys and Conformis market research show that most of the growing total knee replacement patient population is unaware of stark differences in knee replacement systems, and simply receives the brand of knee replacement system used most frequently by their surgeon. Conformis makes fully personalized or patient specific knee systems for each patient using advanced 3D imaging technology, which is designed to produce an implant that matches each patient’s unique anatomy, and is designed to offer multiple benefits to patients and medical facilities that have been demonstrated in peer-reviewed clinical studies: Patients reporting significant higher fulfillment of their expectations regarding post-op function and knee strength. Significant bone sparing as compared to traditional total knee arthroplasty. Lower total direct costs for hospital admissions, with variables such as operative time and length of stay favoring fully personalized implants.
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on CFMS:
- Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement Procedures
- Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial Results
- Conformis, Inc. to Participate in Upcoming Investor Conferences
- Conformis, Bodycad enter settlement and license agreement
- Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent Litigation